Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects
In the golden age of pharmaceutical nanocarriers, we are witnessing a maturation stage of
the original concepts and ideas. There is no doubt that nanoformulations are extremely …
the original concepts and ideas. There is no doubt that nanoformulations are extremely …
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Five small interfering RNA (siRNA)-based therapeutics have been approved by the Food
and Drug Administration (FDA), namely patisiran, givosiran, lumasiran, inclisiran, and …
and Drug Administration (FDA), namely patisiran, givosiran, lumasiran, inclisiran, and …
Nanostructured particles assembled from natural building blocks for advanced therapies
Advanced treatments based on immune system manipulation, gene transcription and
regulation, specific organ and cell targeting, and/or photon energy conversion have …
regulation, specific organ and cell targeting, and/or photon energy conversion have …
Physiological barriers and strategies of lipid‐based nanoparticles for nucleic acid drug delivery
Lipid‐based nanoparticles (LBNPs) are currently the most promising vehicles for nucleic
acid drug (NAD) delivery. Although their clinical applications have achieved success, the …
acid drug (NAD) delivery. Although their clinical applications have achieved success, the …
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
S Yonezawa, H Koide, T Asai - Advanced drug delivery reviews, 2020 - Elsevier
Small interfering RNA (siRNA) has been expected to be a unique pharmaceutic for the
treatment of broad-spectrum intractable diseases. However, its unfavorable properties such …
treatment of broad-spectrum intractable diseases. However, its unfavorable properties such …
Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers–a systematic review of in vitro data
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) were developed as
alternative to other colloidal carriers. They were designed to overcome lipid nanoemulsions …
alternative to other colloidal carriers. They were designed to overcome lipid nanoemulsions …
The impact of variables on particle size of solid lipid nanoparticles and nanostructured lipid carriers; a comparative literature review
LAS Bahari, H Hamishehkar - Advanced pharmaceutical …, 2016 - pmc.ncbi.nlm.nih.gov
During the past decade, pharmaceutical science has seen rapid growth in interest for
nanoscale materials. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers …
nanoscale materials. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers …
[HTML][HTML] siRNA therapeutics and its challenges: recent advances in effective delivery for cancer therapy
A Paul, A Muralidharan, A Biswas, BV Kamath… - OpenNano, 2022 - Elsevier
Small interfering RNA (siRNA) has emerged as a promising strategy for treating several
“undruggable” genetically impaired conditions. The siRNA-based drugs have opened the …
“undruggable” genetically impaired conditions. The siRNA-based drugs have opened the …
Solid lipid nanoparticles: a promising nanomaterial in drug delivery
K Rajpoot - Current pharmaceutical design, 2019 - benthamdirect.com
The solid lipid nanoparticles (SLNs) usually consists of active drug molecules along with
solid lipids, surfactants, and/or co-surfactants. They possess some potential features such as …
solid lipids, surfactants, and/or co-surfactants. They possess some potential features such as …
In vivo photoacoustic imaging of livers using biodegradable hyaluronic acid‐conjugated silica nanoparticles
The diagnosis of liver diseases is generally carried out via ultrasound imaging, computed
tomography, and magnetic resonance imaging. The emerging photoacoustic imaging is an …
tomography, and magnetic resonance imaging. The emerging photoacoustic imaging is an …